| Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling K Sharma, RCJ D’Souza, S Tyanova, C Schaab, JR Wiśniewski, J Cox, ... Cell reports 8 (5), 1583-1594, 2014 | 1057 | 2014 |
| Uncovering global SUMOylation signaling networks in a site-specific manner IA Hendriks, RCJ D'souza, B Yang, M Verlaan-de Vries, M Mann, ... Nature structural & molecular biology 21 (10), 927-936, 2014 | 553 | 2014 |
| Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles SJ Deeb, RCJ D'Souza, J Cox, M Schmidt-Supprian, M Mann Molecular & Cellular Proteomics 11 (5), 77-89, 2012 | 219 | 2012 |
| A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma BW Stringer, BW Day, RCJ D’Souza, PR Jamieson, KS Ensbey, ZC Bruce, ... Scientific reports 9 (1), 4902, 2019 | 193 | 2019 |
| Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation N Nagaraj, RCJ D’Souza, J Cox, JV Olsen, M Mann Journal of proteome research 9 (12), 6786-6794, 2010 | 193 | 2010 |
| System-wide identification of wild-type SUMO-2 conjugation sites IA Hendriks, RC D’Souza, JG Chang, M Mann, ACO Vertegaal Nature communications 6 (1), 7289, 2015 | 127 | 2015 |
| Regulation of liver metabolism by the endosomal GTPase Rab5 A Zeigerer, RL Bogorad, K Sharma, J Gilleron, S Seifert, S Sales, ... Cell reports 11 (6), 884-892, 2015 | 56 | 2015 |
| Intratumoural heterogeneity underlies distinct therapy responses and treatment resistance in glioblastoma S Akgül, AM Patch, RCJ D’souza, P Mukhopadhyay, K Nones, S Kempe, ... Cancers 11 (2), 190, 2019 | 55 | 2019 |
| Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-β RC J. D’Souza, AM Knittle, N Nagaraj, M van Dinther, C Choudhary, ... Science signaling 7 (335), rs5-rs5, 2014 | 53 | 2014 |
| PknH, a transmembrane Hank's type serine/threonine kinase from Mycobacterium tuberculosis is differentially expressed under stress conditions K Sharma, H Chandra, PK Gupta, M Pathak, A Narayan, LS Meena, ... FEMS microbiology letters 233 (1), 107-113, 2004 | 49 | 2004 |
| The dystroglycan receptor maintains glioma stem cells in the vascular niche BW Day, JD Lathia, ZC Bruce, RCJ D’Souza, U Baumgartner, KS Ensbey, ... Acta neuropathologica 138, 1033-1052, 2019 | 27 | 2019 |
| Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D Culture RCJ D'Souza, C Offenhäuser, J Straube, U Baumgartner, A Kordowski, ... Cells 9 (2), 267, 2020 | 25 | 2020 |
| Reactive oxygen species and upregulation of NADPH oxidases in mechanotransduction of embryonic stem cells H Sauer, C Ruhe, JP Müller, M Schmelter, R D’Souza, M Wartenberg Advanced Protocols in Oxidative Stress I, 397-418, 2008 | 21 | 2008 |
| Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore YC Lim, KS Ensbey, C Offenhäuser, RCJ D’souza, JK Cullen, BW Stringer, ... Neuro-oncology 22 (2), 216-228, 2020 | 18 | 2020 |
| Correction to feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation N Nagaraj, RCJ D’Souza, J Cox, JV Olsen, M Mann Journal of proteome research 11 (6), 3506-3508, 2012 | 14 | 2012 |
| Preventing recurrence in Sonic hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179 Y Li, C Lim, T Dismuke, DS Malawsky, S Oasa, ZC Bruce, C Offenhäuser, ... Research square, rs. 3. rs-2949436, 2023 | 5 | 2023 |
| Targeting OLIG2 increases therapeutic responses in SHH medulloblastoma mouse models and patient-derived medulloblastoma organoids Y Li, T Dismuke, C Lim, ZC Bruce, C Offenhäuser, U Baumgartner, ... bioRxiv, 2022.02. 14.480293, 2022 | 2 | 2022 |
| Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179 Y Li, C Lim, T Dismuke, DS Malawsky, S Oasa, ZC Bruce, C Offenhäuser, ... Nature Communications 16 (1), 1091, 2025 | 1 | 2025 |
| EphA3 CAR T cells are effective against glioblastoma in preclinical models P Martins, RCJ D’Souza, N Skarne, L Lekieffre, S Horsefield, ... Journal for immunotherapy of cancer 12 (8), e009403, 2024 | 1 | 2024 |
| P02. 12. B UNDERSTANDING THE ROLES OF EPHRIN A5 IN GLIOBLASTOMA AND ITS POTENTIAL AS A THERAPEUTIC TARGET N Skarne, R D'Souza, L Harris, U Baumgartner, C Offenhauser, S Akgül, ... Neuro-Oncology 25 (Suppl 2), ii32, 2023 | 1 | 2023 |
Matthias MannMax Planck Institute of Biochemistry, Munich and CPR, University of CopenhagenEmail verificata su biochem.mpg.de